Alembic Pharma Q4 net profit rises 15% to Rs 70 crore

Company's net sales during the reported quarter rose 8.30% to Rs 501.83 crore

Press Trust of India New Delhi
Last Updated : Apr 27 2015 | 5:20 PM IST
Vadodara-based drug firm Alembic Pharmaceuticals today reported 14.74 per cent increase in net profit at Rs 70.33 crore for the quarter ended March 31, 2015.

The company had reported a net profit of Rs 61.29 crore in the corresponding period a year ago.

Alembic Pharmaceuticals' net sales during the reported quarter rose 8.30 per cent to Rs 501.83 crore as against Rs 463.33 crore in the same quarter of previous fiscal.

Also Read

For the year ended March 31, 2015, net profit increased by 20.14 per cent to Rs 282.93 crore as compared to Rs 235.5 crore last year.

Net sales grew by 10.31 per cent in financial year 2014-15 at Rs 2,052.68 crore as against Rs 1,860.7 crore in the previous fiscal.

Meanwhile, in a separate filing, the company's Board said it has recommended a dividend of Rs 3.50 per equity share.

Alembic Pharmaceuticals shares closed 3.02 per cent down at Rs 34.25 apiece on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2015 | 3:56 PM IST

Next Story